first glp 1 drug How GLP-1 medications are transforming diabetes and weight loss treatment FDA Approves First Oral GLP-1
Description
Key Difference: Tirzepatide (Mounjaro/Zepbound): Dual GIP/GLP-1 agonist Semaglutide (Wegovy/Ozempic): GLP-1 agonist only Effectiveness Difference: Tirzepatide: 15-22% average body weight loss Semaglutide: 10-15% average body weight loss Semaglutide is less potent but still highly effective and significantly more affordable than brand-name tirzepatide

you can not exceed this dosage

Combine with: Balanced nutrition Light exercise Proper hydration for best long-term fat loss and wellness

Since the latter is a version of semaglutide, which is typically given by injection, its been specially formulated to be taken orally
